NCT02466997View on ClinicalTrials.gov

Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 23, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Vitiligo
Interventions
DRUG

tacrolimus

tacrolimus 0.1% ointment applied twice a day for the experimental group during 24 weeks placebo ointment applied twice a day for the control group during 24 weeks

DRUG

Placebo

Trial Locations (4)

33000

University Hospital of Bordeaux - St André Hospital, Bordeaux

35000

University Hospital Center of Rennes - Hôpital Pontchaillou, Rennes

72000

Regional Hospital Center of Le Mans -, Le Mans

06000

University Hospital Center of Nice - Hôpital de l'Archet, Nice

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT02466997 - Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC | Biotech Hunter | Biotech Hunter